Riluzole for amyotrophic lateral sclerosis.
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy* / Q000503:physiopathology; D018849:Controlled Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D018691:Excitatory Amino Acid Antagonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D018698:Glutamic Acid / Q000187:drug effects*; D006801:Humans; D009132:Muscles / Q000187:drug effects / Q000503:physiopathology; D019782:Riluzole; D015222:Sodium Channels / Q000187:drug effects; D013844:Thiazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D014139:Tracheostomy; D016896:Treatment Outcome
D018691:Excitatory Amino Acid Antagonists; D015222:Sodium Channels; D013844:Thiazoles; D018698:Glutamic Acid; D019782:Riluzole